price
EP
NASDAQ · EPRX
Eupraxia Pharmaceuticals Inc.
Healthcare · Biotechnology
$6.85
Up+$0.17 (+2.42%)
Updated Aug 19, 2026, 1:45 PM
SID Score
4.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 216.11M
- P/E ratio
- -7.17
- Dividend yield
- 0.00%
- 52-week range
- $5.04 – $9.32
- Volume
- 379.17K
- Avg. volume
- 144.03K
Price performance
EPRX price history
1M range · 21 trading sessions · Daily adjusted prices
EPRX closed at $6.85 after 21 trading sessions, up 7.37% for the selected period.
- Last close
- $6.85
- Period change
- +7.37%
- Period low
- $5.81
- Period high
- $6.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $6.81 | $6.88 | $6.715 | $6.85 | 379.17K |
| Aug 17, 2026 | $6.72 | $6.89 | $6.65 | $6.82 | 127.28K |
| Aug 14, 2026 | $6.66 | $6.72 | $6.46 | $6.72 | 164.66K |
| Aug 13, 2026 | $6.70 | $6.87 | $6.495 | $6.67 | 255.9K |
| Aug 12, 2026 | $6.79 | $6.79 | $6.41 | $6.48 | 220.93K |
| Aug 11, 2026 | $6.67 | $6.86 | $6.66 | $6.70 | 181.02K |
| Aug 10, 2026 | $6.77 | $6.885 | $6.66 | $6.66 | 270.22K |
| Aug 7, 2026 | $6.84 | $6.87 | $6.57 | $6.77 | 475.86K |
| Aug 6, 2026 | $6.43 | $6.71 | $6.40 | $6.66 | 199.72K |
| Aug 5, 2026 | $6.57 | $6.70 | $6.44 | $6.48 | 100.39K |
| Aug 4, 2026 | $6.40 | $6.645 | $6.36 | $6.52 | 258.77K |
| Aug 3, 2026 | $6.40 | $6.68 | $6.325 | $6.51 | 98.46K |
| Jul 31, 2026 | $6.55 | $6.74 | $6.15 | $6.40 | 457.16K |
| Jul 30, 2026 | $6.01 | $6.60 | $5.975 | $6.55 | 1.1M |
| Jul 29, 2026 | $6.10 | $6.25 | $5.79 | $5.97 | 784.95K |
| Jul 28, 2026 | $6.13 | $6.24 | $5.92 | $6.10 | 511.79K |
| Jul 27, 2026 | $5.86 | $6.28 | $5.76 | $6.17 | 326.17K |
| Jul 24, 2026 | $6.37 | $6.37 | $5.72 | $5.81 | 892.5K |
| Jul 23, 2026 | $6.40 | $6.42 | $6.18 | $6.30 | 192.67K |
| Jul 22, 2026 | $6.44 | $6.83 | $6.395 | $6.42 | 901.7K |
| Jul 21, 2026 | $6.32 | $6.57 | $6.1809 | $6.38 | 114.38K |
Latest EPRX news
The latest Smart Investors Daily articles mentioning EPRX.
Stock researchResearch & News · SEC Filings
Loading stock research…

